- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/16 - Peri-condensed systems
Patent holdings for IPC class C07D 498/16
Total number of patents in this class: 247
10-year publication summary
|
14
|
14
|
10
|
8
|
18
|
13
|
16
|
17
|
39
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3751 |
12 |
| Merck Patent GmbH | 5815 |
10 |
| Genentech, Inc. | 3976 |
9 |
| ImmunoGen, Inc. | 401 |
8 |
| Bristol-myers Squibb Company | 4880 |
7 |
| Gilead Sciences, Inc. | 2032 |
7 |
| Gilead Pharmasset LLC | 41 |
6 |
| Incyte Holdings Corporation | 666 |
6 |
| Turning Point Therapeutics, Inc. | 100 |
6 |
| Lupin Limited | 432 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 703 |
4 |
| Universal Display Corporation | 1924 |
4 |
| Fulcrum Therapeutics, Inc. | 65 |
4 |
| Jacobio Pharmaceuticals Co., Ltd. | 100 |
4 |
| Nikang Therapeutics, Inc. | 95 |
4 |
| Shanghai Blueray Biopharma Co., Ltd. | 27 |
4 |
| Samsung Display Co., Ltd. | 34907 |
3 |
| Bayer AG | 3325 |
3 |
| The Board of Trustees of the University of Illinois | 2702 |
3 |
| The Broad Institute, Inc. | 1827 |
3 |
| Other owners | 135 |